Welcome to our dedicated page for Steris Plc SEC filings (Ticker: STE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
STERIS plc filings document material events for an Ireland-incorporated operating company with ordinary shares traded as STE on the New York Stock Exchange. Recent Form 8-K reports cover results of operations and financial condition, attached earnings releases, director appointments and retirements, officer transition arrangements, and compensation-related amendments.
The filing record also identifies STERIS securities registered under Section 12(b), including ordinary shares and NYSE-listed senior notes due 2031 and 2051. These disclosures frame the company’s capital structure, governance actions, executive-compensation matters, and periodic operating-result announcements for its infection-prevention and life sciences business.
STERIS plc Senior Vice President and CFO Karen L. Burton reported a routine tax-withholding transaction. On June 4, 2026, 90 ordinary shares were withheld at $212.24 per share from 306 restricted shares that vested to cover required taxes, not an open-market sale.
After this transaction, Burton directly holds 13,184 ordinary shares, including 9,282 restricted shares as of June 8, 2026, which are scheduled to lapse in stages between October 1, 2026 and June 4, 2029.
STERIS plc senior vice president and general counsel John Adam Zangerle reported a routine tax-withholding transaction related to vested stock. On June 3, 2026, 365 ordinary shares were withheld from 1,252 restricted shares that vested, using the NYSE closing price of $210.19 per share to cover required taxes. After this withholding, he directly holds 37,079 ordinary shares. As of June 3, 2026, 9,615 of these shares remain restricted, with restrictions scheduled to lapse in several tranches between June 4, 2026 and June 4, 2029.
STERIS plc executive Renato Tamaro reported a routine tax-related share withholding tied to restricted stock vesting. On June 3, 2026, 64 ordinary shares valued at $210.19 per share were withheld to cover taxes from 217 restricted shares that vested that day. After this transaction, Tamaro directly owned 6,259 ordinary shares, of which 1,626 remained restricted and will vest in scheduled tranches between June 2026 and June 2029. This event reflects compensation and tax mechanics rather than an open-market sale.
STERIS plc senior executive Julia Madsen reported a routine tax-withholding transaction linked to restricted share vesting. On June 3, 2026, 239 ordinary shares valued at $210.19 per share were withheld from 666 restricted shares that vested, to cover taxes determined under applicable laws using the NYSE closing price.
After this withholding, Madsen directly held 12,452 ordinary shares, including 4,732 restricted shares as of June 3, 2026. These restricted shares are scheduled to lapse in stages between June 4, 2026 and June 4, 2029.
STERIS plc senior executive Kenneth E. Kohler reported a routine tax-withholding transaction related to restricted stock vesting. On June 3, 2026, 184 ordinary shares were withheld at a value of $210.19 per share to cover taxes on 630 restricted shares that vested that day.
After this tax-withholding disposition, Kohler directly holds 11,482 ordinary shares of STERIS, of which 4,485 remain restricted as of June 3, 2026. These restricted shares are scheduled to lapse in stages between June 4, 2026 and June 4, 2029, reflecting ongoing equity-based compensation rather than open-market trading.
STERIS plc senior executive handles tax withholding on vested shares. SVP & Chief HRO Mary Clare Fraser had 311 ordinary shares withheld on June 3, 2026 to cover taxes on 835 restricted shares that vested, based on the NYSE closing price that day. After this non-market tax-withholding disposition, she directly holds 14,316 ordinary shares, including 6,719 restricted shares scheduled to lapse in stages between June 4, 2026 and June 4, 2029.
STERIS plc President and CEO Daniel A. Carestio reported a routine tax-withholding transaction related to vesting restricted stock. On June 3, 2026, 2,619 ordinary shares were withheld at $210.19 per share to cover employment and tax obligations when 5,937 restricted shares vested.
After this withholding, he directly owned 69,964 ordinary shares, including 44,176 restricted shares as of June 3, 2026. These restricted shares are scheduled to lapse in stages between June 4, 2026 and June 4, 2029.
STERIS plc Senior Vice President and CFO Karen L. Burton reported an automatic share disposition tied to tax withholding. On June 3, 2026, 190 ordinary shares were withheld from 651 restricted shares that vested, using the NYSE closing price of $210.19 per share to determine the tax value. This was not an open‑market sale but a payment of taxes in shares.
After this transaction, Burton directly holds 13,274 ordinary shares, of which 9,588 remain restricted as of June 3, 2026. Those restricted shares are scheduled to lapse in stages between June 4, 2026 and June 4, 2029.
STERIS plc insider files Form 144 to sell shares. Director or reporting person Daniel A. Carestio reported transactions tied to equity compensation. The filing lists 1,374 shares associated with a restricted stock lapse on 06/02/2026 and shows 3,054 shares sold during the prior three months on 06/04/2026 for $655,511.00.
STERIS plc senior vice president and general counsel John Adam Zangerle reported routine equity compensation activity and related tax withholding. On June 2, 2026, 247 ordinary shares were withheld to cover taxes on 846 restricted shares that vested, reflecting a tax-withholding disposition rather than an open-market sale.
The same day, he received 4,359 ordinary shares as a grant at no cost and was granted employee stock options for 15,200 ordinary shares with a $230.74 exercise price, vesting in four annual installments from 2027 through 2030 and expiring on June 2, 2036. Following these awards, he directly holds 37,691 ordinary shares, of which 10,867 are restricted as of June 2, 2026.